J&J, MacroGenics in second antibody deal

MacroGenics Inc. (NASDAQ:MGNX) jumped $3.02 (17%) to $21.06 on Wednesday after granting the Janssen Biotech

Read the full 152 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE